Medical Videoscope Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Global Medical Videoscope Market Trends and Insights

Rising Endoscopy Volumes From GI, Respiratory, And Urologic Disease Burdens

Demographic shifts toward aging populations and the increasing prevalence of chronic diseases are driving higher volumes of gastrointestinal, pulmonary, and urologic procedures, sustaining the demand for videoscope platforms. Australia's National Lung Cancer Screening Program, launched in 2025, conducted 37,000 low-dose CT scans in its initial five months, identifying 426 high-risk nodules for bronchoscopic evaluation.^{[1]Australian Government Department of Health, “National Lung Cancer Screening Program Update,” HEALTH.GOV.AU} In the United States, lung cancer screening eligibility expanded in 2024, removing the 15-year post-smoking limit and lowering the age threshold to 50 for individuals with a 20-pack-year smoking history, effectively doubling the eligible population. Navigational bronchoscopy and robotic-assisted platforms are increasingly preferred over percutaneous biopsy due to their ability to significantly reduce pneumothorax risk from 28.3% to 3.3% in comparative studies. Similar growth trends are observed in colorectal, bladder, and upper-GI procedures, driven by broader screening programs and the transition from open surgery to therapeutic endoscopy.

Shift To Minimally Invasive Surgery And Outpatient/ASC Sites Of Care

Payment reforms and capacity constraints are shifting procedures from inpatient departments to ambulatory surgical centers (ASCs). Between 2017 and 2024, the number of Medicare-certified endoscopy ASCs in the United States increased by 46.7%, accompanied by a parallel rise in ASC spending on gastrointestinal procedures.^{[2]American Medical Association, “Physician Practice Benchmark Survey,” AMA-ASSN.ORG} ASCs are increasingly adopting leasing arrangements and single-use scopes, contributing to a 6.35% compound annual growth rate (CAGR) in disposable videoscopes. Additionally, the consolidation of physician employment, with 78% of U.S. physicians working for hospitals or corporations in 2023, is centralizing procurement decisions and encouraging the adoption of standardized, AI-ready tower platforms.^{[3]NHS England, “Endoscopy Workforce and Capacity Report,” ENGLAND.NHS.UK}

Rapid Upgrades To 4K/UHD, 3D, NIR/Fluorescence, And AI-Assisted Visualization

Surgeons are increasingly prioritizing advanced visualization technologies that enhance tissue detail, perfusion mapping, and automated lesion detection. A recently introduced platform combines 4K optics with blue-light and linked-color imaging to highlight mucosal abnormalities without the need for dyes. Another system integrates 4K with near-infrared fluorescence, enabling real-time visualization of bile ducts during procedures. A 3D system enhances depth perception in laparoscopy and arthroscopy. Studies have shown that near-infrared guidance in colorectal surgeries reduces positive resection margins by 18%. Hospitals are justifying the high costs of these technologies, which often exceed USD 150,000, by leveraging their appeal to referring clinicians and payers.

Infection-Prevention Push Accelerating Adoption Of Single-Use Videoscopes

Growing concerns over duodenoscope contamination and stricter reprocessing standards are accelerating the adoption of disposable designs. A newly approved single-use cystoscope extends high-definition imaging capabilities into a disposable format. Disposable bronchoscopes and gastroscopes eliminate the need for costly automated reprocessors, which can cost up to USD 100,000, while also reducing turnaround times. Many hospitals are adopting a hybrid approach, reserving single-use devices for high-risk procedures or immunocompromised patients and relying on reusable scopes for routine cases.

High Capital Intensity And Lifecycle Service/Repair Costs

Smaller facilities and hospitals in emerging markets face significant financial challenges due to substantial upfront equipment investments and ongoing maintenance expenses. These factors limit market penetration and extend replacement cycles. An endoscopy tower, which includes a processor, light source, insufflator, and display, can cost over USD 200,000. Adding 4K or 3D capabilities increases the cost to over USD 300,000. In 2024, the total cost per endoscopy procedure was estimated at approximately USD 135, with equipment depreciation and service contracts accounting for 22% of the total. Repairing flexible videoscopes typically incurs an average cost of USD 1,200 per incident. Preventive-maintenance protocols have proven effective in reducing repair costs, with one high-volume academic center cutting annual repair expenses from USD 1.2 million to USD 724,000. Leasing models and refurbished-equipment markets have emerged as alternatives to address capital constraints. However, these options often exclude the latest imaging modalities and AI-enabled processors, perpetuating a technology gap between well-funded tertiary centers and community hospitals.

Reprocessing Complexity And Regulatory Scrutiny Increasing Compliance Burden

Rising infection-control standards and increased regulatory scrutiny are driving up the labor, time, and documentation requirements for reprocessing flexible endoscopes, leading to higher operational costs and inefficiencies. Enhanced cleaning protocols introduced in recent years have added USD 52 to USD 68 per reprocessing cycle and extended turnaround times by 24 minutes, creating throughput challenges in high-volume endoscopy suites. Regulatory directives now mandate periodic microbiologic surveillance and culture testing, requiring dedicated laboratory capacity and skilled personnel. Stricter post-market surveillance and traceability requirements have also compelled manufacturers to redesign scopes with simplified channel geometries and disposable components to facilitate cleaning. Many endoscopy centers report difficulties in recruiting qualified reprocessing technicians and cite inadequate space for dedicated reprocessing rooms. These compliance burdens disproportionately impact smaller ASCs and office-based practices, accelerating their adoption of single-use devices despite the higher per-procedure costs.

Segment Analysis

By Scope Design: Single-Use Gains Despite Reusable Dominance

In 2025, reusable flexible scopes accounted for 53.10% of the revenue, highlighting their cost efficiency in high-volume gastroenterology suites. However, with stricter infection control mandates, single-use models are projected to grow at a compound annual growth rate (CAGR) of 6.35% through 2031. Ambu’s aScope 5 Cysto HD offers high-definition imaging while eliminating reprocessing delays. In January 2026, Olympus introduced the SecureFlex single-use biopsy device to address cross-contamination concerns in pancreatic procedures. Adoption trends indicate that gastroenterology continues to favor reusable scopes for colonoscopies, whereas pulmonology and urology increasingly prefer disposable scopes in intensive care and emergency settings due to their immediate availability.

By Clinical Application: Pulmonology Surges On Lung-Cancer Screening

In 2025, gastroenterology led the market with 42.40% of the revenue, driven by colorectal cancer screenings and therapeutic interventions. Pulmonology, however, is expected to grow at an annual rate of 6.46%, supported by expanded screening eligibility and advancements in robotic bronchoscopy, which have significantly improved diagnostic sensitivity to 85%. National screening programs in Australia and pilot initiatives in China are further accelerating this growth. As these programs mature, pulmonology is anticipated to narrow its revenue gap with gastroenterology in the medical videoscope market.

By End User: ASCs Ride the Wave of Outpatient Migration

Hospitals remained the largest buyer segment in 2025, accounting for 42.56% of spending, driven by the complexity of procedures such as ERCP, EUS, and emergency services. However, spending in Ambulatory Surgery Centers (ASCs) and ambulatory endoscopy centers is growing at a CAGR of 6.36%, fueled by payer incentives for lower-cost care settings and increased physician ownership stakes. Over the past seven years, the number of ASCs in the United States has risen by nearly 47%. The combination of capital-light leasing models and disposable scopes aligns well with ASC cash flow requirements, driving their increasing share in the medical videoscope market.

By Imaging/Resolution: Surge in 4K Adoption

High-definition systems accounted for 44.80% of the revenue in 2025, but 4K and ultra-HD technologies are growing at a CAGR of 6.39%, driven by the demand for enhanced margin visualization during surgeries. FUJIFILM’s Eluxeo 8000 enhances flat adenoma detection with linked-color imaging. Mindray’s UX5 incorporates near-infrared fluorescence for precise anatomy mapping, while KARL STORZ’s RUBINA 3D platform reduces learning curves in arthroscopy. These technological advancements are expected to drive premium imaging systems toward a dominant position in the medical videoscope market by the end of the forecast period.

Geography Analysis

In 2025, North America accounted for 32.19% of the revenue, driven by extensive ASC networks, strong reimbursement systems, and rapid adoption of AI-ready processors. The region's growth aligns with the global 6.08% CAGR but is moderated by market maturity and staffing constraints. Additionally, regulatory safety alerts regarding duodenoscope reprocessing are accelerating the transition to single-use instruments. Canada and Mexico are investing in colon cancer screening programs, although their budgets remain lower compared to those of the United States.

Europe is prioritizing reusable scopes, supported by stringent reprocessing protocols. Regulatory changes under the EU Medical Device Regulation are compelling suppliers to simplify channel geometries. Furthermore, France's 2025 guidelines recommend limiting the use of disposable scopes to high-risk cases. However, sustainability concerns are hindering the growth of single-use instruments in Western Europe.

Asia-Pacific is the fastest-growing region, with a 6.43% CAGR. China's localization initiatives enabled a major manufacturer to secure regulatory approval for domestically produced gastroscopes in September 2025, opening opportunities in public procurement. Additionally, Australia's nationwide screening programs and India's rapid hospital infrastructure development are driving regional demand. In Japan, despite stagnant population growth, the aging population sustains high procedure volumes.

The Middle East, Africa, and South America represent smaller market shares but demonstrate significant growth potential. Gulf Cooperation Council countries are investing in advanced 4K systems to strengthen their medical tourism offerings. Meanwhile, Brazil is incorporating endoscopy expansion into its national cancer-control strategies. However, these regions face challenges such as currency fluctuations and import restrictions.